Studies of Tau in neuronally-derived exosomes isolated from plasma of AD patients indicate that levels of phosphorylated Tau (p-Tau) predict conversion of MCI (mild cognitive impairment) to AD dementia (17). The gene discussed is MAPT; the disease is Alzheimer disease.